• Home >
  • Publications >
  • Targeting autophagy plus high-dose CDK4/6 inhibitors in advanced HR+HER2− breast cancer: A phase 1b/2 trial

Targeting autophagy plus high-dose CDK4/6 inhibitors in advanced HR+HER2− breast cancer: A phase 1b/2 trial

27 Dec 2024Med

DOI : 10.1016/j.medj.2024.11.012

Members

CHUNLONG CHEN

CNRS Research Director